Clinical study for the effect of Zhizhen Fang on postoperative adjuvant chemotherapy in patients with stage III colorectal cancer

Phase 1

• Conditions: Colorectal cancer

• Registration Number: ITMCTR2000003686
• Lead Sponsor: Shanghai General Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 20 February 2023

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

(1) The pathological diagnosis was consistent with colorectal cancer and the clinicopathological stage was stage III post operation;
(2) The syndrome differentiation was in accordance with the TCM syndrome of spleen deficiency and qi stagnation;
(3) Patients with chemotherapy indications and initial chemotherapy after operation;
(4) The KPS score was above 60;
(5) The age ranged from 18 to 75 years old;
(6) The expected survival time was more than 6 months;
(7) The function of important organs was normal, blood routine test, liver and kidney function and electrocardiogram were normal;
(8) There was no abnormal mental state, who could understand and sign the informed consent.

Exclusion Criteria

(1) Combined with important organ or blood system diseases;
(2) Severe allergic constitution;
(3) Pregnant or lactating women;
(4) There are mental disorders and can not cooperate.

Study & Design

• Study Type: Interventional study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Judgment of TCM syndrome curative effect;